Shareholders who purchased shares of PATH during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. https://securitiesclasslaw.com/securities/uipath-loss-submission-form-2/?id=88059&from=3 ALLEGATIONS: According to the complaint, it alleges that throughout the Class Period, defendants made materially false and misleading statements concerning the success of UiPath's turnaround str ...